Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
An Exploratory Study Assessing the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Sponsor: Capital Medical University
Listed as NCT06361823, this PHASE3 trial focuses on Idiopathic Intracranial Hypertension and remains actively recruiting participants. Sponsored by Capital Medical University, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Capital Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.